Business · 17/11/2014Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 14 New Drug Applications from Smith Miller and Patch, Inc. and Others
Summary
The FDA is revoking approvals of 14 new drug applications submitted by multiple companies due to repeated failure to submit required annual reports.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →